Proto Labs Inc (PRLB) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Proto Labs’s revenue went from $298M in fiscal 2016 to $533M in fiscal 2025, growth of about 6.7% a year.
Net income in fiscal 2025 was $21M, a net margin of 4.0%; the best year in this period was 2018 with $77M.
Over the twelve months to September 30, 2026, revenue was $579M and net income $35M.
Free cash flow was $60M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 9% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $579M | $533M | $501M | $504M | $488M | $488M | $434M | $459M | $446M | $344M | $298M |
| Gross profit | $262M | $237M | $223M | $222M | $215M | $223M | $218M | $235M | $239M | $194M | $167M |
| Operating income | $42M | $25M | $20M | $28M | -$98M | $40M | $60M | $80M | $89M | $72M | $62M |
| Net income | $35M | $21M | $17M | $17M | -$103M | $33M | $51M | $64M | $77M | $52M | $43M |
| EPS (diluted) | $1.43 | $0.88 | $0.66 | $0.66 | $-3.77 | $1.21 | $1.89 | $2.35 | $2.81 | $1.93 | $1.61 |
| R&D | $43M | $43M | $41M | $40M | $38M | $44M | $37M | $33M | $29M | $24M | $22M |
| Revenue growth | — | +6.4% | −0.6% | +3.2% | +0.1% | +12.4% | −5.3% | +2.9% | +29.3% | +15.6% | +12.8% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $72M | $75M | $78M | $73M | $62M | $55M | $107M | $116M | $123M | $82M | $77M |
| Capital spending | -$24M | -$15M | -$9M | -$28M | -$22M | -$34M | -$47M | -$62M | -$87M | -$33M | -$34M |
| Free cash flow | $49M | $60M | $69M | $45M | $40M | $21M | $60M | $54M | $36M | $49M | $44M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $16M | $43M | $60M | $44M | $30M | $23M | $15M | $34M | $12M | $4M | — |
| Stock-based pay | $14M | $16M | $17M | $16M | $18M | $19M | $15M | $11M | $11M | $9M | $7M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $128M | $103M | $103M | $80M | $78M | $162M | $161M | $132M | $94M | $108M |
| Debt | — | $3M | $3M | $5M | $4M | $6M | $11M | $12M | — | $5M | $0 |
| Equity | — | $674M | $670M | $695M | $698M | $828M | $644M | $586M | $541M | $461M | $380M |
| Total assets | — | $763M | $744M | $772M | $802M | $929M | $744M | $674M | $619M | $519M | $414M |
| Shares (diluted) | 24M | 24M | 25M | 26M | 27M | 28M | 27M | 27M | 27M | 27M | 27M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 45.2% | 44.5% | 44.6% | 44.1% | 44.1% | 45.6% | 50.1% | 51.3% | 53.6% | 56.3% | 56.0% |
| Operating margin | 7.3% | 4.7% | 4.0% | 5.6% | -20.1% | 8.3% | 13.8% | 17.4% | 20.0% | 21.0% | 20.7% |
| Net margin | 6.0% | 4.0% | 3.3% | 3.4% | -21.2% | 6.8% | 11.7% | 13.9% | 17.2% | 15.0% | 14.3% |
| FCF margin | 8.4% | 11.2% | 13.7% | 9.0% | 8.3% | 4.3% | 13.8% | 11.7% | 8.0% | 14.3% | 14.7% |
| ROIC | — | 2.5% | 2.0% | 2.5% | -11.0% | 4.0% | 7.4% | 10.5% | 13.7% | 10.8% | 10.8% |
| ROE | — | 3.1% | 2.5% | 2.5% | -14.8% | 4.0% | 7.9% | 10.9% | 14.1% | 11.2% | 11.2% |
Frequently asked questions
What is Proto Labs’s annual revenue?
$533M in fiscal 2025 and $579M over the twelve months to September 30, 2026.
How much profit does Proto Labs make?
Net income was $21M in fiscal 2025 (net margin 4.0%).
Is Proto Labs’s revenue growing?
Yes: revenue rose 6.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.